🚀 VC round data is live in beta, check it out!

Avemio Valuation Multiples

Discover revenue and EBITDA valuation multiples for Avemio and similar public comparables like Smoltek Nanotech Holding, ICZOOM Group, Unibap, RocTool and more.

Avemio Overview

About Avemio

Avemio AG Formerly Palgon AG provides management consulting services. It offers marketing, distribution, and other services in the field of information technology, including the Internet and data processing and related fields. Further, the group is also involved in acquiring, selling, renting, and managing real estate.


Founded

2018

HQ

Germany

Employees

N/A

Website

palgon.de

Financials (FY)

Revenue: $103M
EBITDA: ($1M)

EV

$18M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Avemio Financials

Avemio reported last fiscal year revenue of $103M and negative EBITDA of ($1M).

In the same fiscal year, Avemio generated $23M in gross profit, ($1M) in EBITDA losses, and had net loss of ($8M).

Revenue (LTM)


Avemio P&L

In the most recent fiscal year, Avemio reported revenue of $103M and EBITDA of ($1M).

Avemio expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Avemio forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
RevenueXXX$103MXXXXXXXXX
Gross ProfitXXX$23MXXXXXXXXX
Gross MarginXXX22%XXXXXXXXX
EBITDAXXX($1M)XXXXXXXXX
EBITDA MarginXXX(1%)XXXXXXXXX
EBIT MarginXXX(5%)XXXXXXXXX
Net ProfitXXX($8M)XXXXXXXXX
Net MarginXXX(7%)XXXXXXXXX
Net Debt$8MXXXXXXXXX

Financial data powered by Morningstar, Inc.

Avemio Stock Performance

Avemio has current market cap of $7M, and enterprise value of $18M.

Market Cap Evolution


Avemio's stock price is $1.90.

See Avemio trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$18M$7M(0.9%)XXXXXXXXX$-1.96

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Avemio Valuation Multiples

Avemio trades at 0.2x EV/Revenue multiple, and (16.5x) EV/EBITDA.

See valuation multiples for Avemio and 15K+ public comps

EV / Revenue (LTM)


Avemio Financial Valuation Multiples

As of March 10, 2026, Avemio has market cap of $7M and EV of $18M.

Equity research analysts estimate Avemio's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Avemio has a P/E ratio of (1.0x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$7MXXX$7MXXXXXXXXX
EV (current)$18MXXX$18MXXXXXXXXX
EV/RevenueXXX0.2xXXXXXXXXX
EV/EBITDAXXX(16.5x)XXXXXXXXX
EV/EBITXXX(3.5x)XXXXXXXXX
EV/Gross ProfitXXX0.8xXXXXXXXXX
P/EXXX(1.0x)XXXXXXXXX
EV/FCFXXX(65.6x)XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Avemio Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Avemio Margins & Growth Rates

Avemio's revenue in the last fiscal year declined by (12%).

See operational valuation multiples for Avemio and other 15K+ public comps

Avemio Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue GrowthXXX(12%)XXXXXXXXX
EBITDA MarginXXX(1%)XXXXXXXXX
EBITDA GrowthXXX(1163%)XXXXXXXXX
Opex to RevenueXXX27%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Avemio Public Comps

See public comps and valuation multiples for other Electronic Components and Semiconductors comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Smoltek Nanotech HoldingXXXXXXXXXXXXXXXXXX
ICZOOM GroupXXXXXXXXXXXXXXXXXX
UnibapXXXXXXXXXXXXXXXXXX
RocToolXXXXXXXXXXXXXXXXXX
Lightning GroupXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Avemio M&A Activity

Avemio acquired XXX companies to date.

Last acquisition by Avemio was on XXXXXXXX, XXXXX. Avemio acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Avemio

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Avemio Investment Activity

Avemio invested in XXX companies to date.

Avemio made its latest investment on XXXXXXXX, XXXXX. Avemio invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Avemio

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Avemio

When was Avemio founded?Avemio was founded in 2018.
Where is Avemio headquartered?Avemio is headquartered in Germany.
Is Avemio publicly listed?Yes, Avemio is a public company listed on Frankfurt Stock Exchange.
What is the stock symbol of Avemio?Avemio trades under AV2 ticker.
When did Avemio go public?Avemio went public in 2023.
Who are competitors of Avemio?Avemio main competitors are Smoltek Nanotech Holding, ICZOOM Group, Unibap, RocTool.
What is the current market cap of Avemio?Avemio's current market cap is $7M.
What is the current revenue of Avemio?Avemio's last fiscal year revenue is $103M.
What is the current EV/Revenue multiple of Avemio?Current revenue multiple of Avemio is 0.2x.
Is Avemio profitable?No, Avemio is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial